LataMed AI is trading at $3.02 (22% down) today following a sharp reversal of its recent momentum gains. - The company provided a shareholder update on July 8, 2026, regarding its previously announced 5-for-1 forward stock split and mandatory share exchange process. - This corporate action, along with a lack of other significant new catalysts, appears to have triggered profit-taking by micro-cap traders after the stock rallied earlier in the week on its Latin America AI strategy and Colombia expansion news. - The absence of strong new positive catalysts to sustain the prior rally, combined with the corporate action, left shares vulnerable to a fast pullback.